Multiple ligand detection and affinity measurement by ultrafiltration and mass spectrometry analysis applied to fragment mixture screening

Anal Chim Acta. 2015 Jul 30:886:98-106. doi: 10.1016/j.aca.2015.06.017. Epub 2015 Jul 9.

Abstract

Binding affinity of a small molecule drug candidate to a therapeutically relevant biomolecular target is regarded the first determinant of the candidate's efficacy. Although the ultrafiltration-LC/MS (UF-LC/MS) assay enables efficient ligand discovery for a specific target from a mixed pool of compounds, most previous analysis allowed for relative affinity ranking of different ligands. Moreover, the reliability of affinity measurement for multiple ligands with UF-LC/MS has hardly been strictly evaluated. In this study, we examined the accuracy of K(d) determination through UF-LC/MS by comparison with classical ITC measurement. A single-point K(d) calculation method was found to be suitable for affinity measurement of multiple ligands bound to the same target when binding competition is minimized. A second workflow based on analysis of the unbound fraction of compounds was then developed, which simplified sample preparation as well as warranted reliable ligand discovery. The new workflow implemented in a fragment mixture screen afforded rapid and sensitive detection of low-affinity ligands selectively bound to the RNA polymerase NS5B of hepatitis C virus. More importantly, ligand identification and affinity measurement for mixture-based fragment screens by UF-LC/MS were in good accordance with single ligand evaluation by conventional SPR analysis. This new approach is expected to become a valuable addition to the arsenal of high-throughput screening techniques for fragment-based drug discovery.

Keywords: Affinity measurement; Fragment library screening; Multiple ligand detection; NS5B; Ultrafiltration-LC/MS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / chemistry*
  • Antiviral Agents / pharmacology*
  • Chromatography, Liquid / economics
  • Chromatography, Liquid / methods
  • Drug Discovery / economics
  • Drug Discovery / methods*
  • Hepacivirus / drug effects
  • Hepacivirus / metabolism*
  • Hepatitis C / drug therapy
  • Hepatitis C / virology*
  • High-Throughput Screening Assays / economics
  • High-Throughput Screening Assays / methods
  • Humans
  • Ligands
  • Mass Spectrometry / economics
  • Mass Spectrometry / methods
  • Protein Binding
  • Reproducibility of Results
  • Ultrafiltration / economics
  • Ultrafiltration / methods
  • Viral Nonstructural Proteins / metabolism*
  • Workflow

Substances

  • Antiviral Agents
  • Ligands
  • Viral Nonstructural Proteins
  • NS-5 protein, hepatitis C virus